ResearcherKyushu UniversityActive in the last 2 years
Kazuhide Matsumoto
Matched on ORCID iD 0000-0003-0842-6500; OpenAlex author ID A5103270945. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 7
- Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-025-03633-4↗
- Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. Co-author DOI 10.1007/s00535-024-02103-0↗
- Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship with the prognosis Co-author DOI 10.21203/rs.3.rs-4088010/v1↗
- Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospe… Co-author DOI 10.1111/ajco.13903↗
- Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study. Co-author DOI 10.1007/s12672-021-00462-1↗
- Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer. Co-author DOI 10.1186/s12885-022-10207-0↗
- Colonic varices: a rare complication of pancreatic cancer. Co-author DOI 10.1007/s12328-020-01225-1↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Katsuhito Teramatsu · 7 shared papers, 2020–2026 · strength 1.16
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Nao Fujimori · 7 shared papers, 2020–2026 · strength 1.16
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Yoshihiro Ogawa · 7 shared papers, 2020–2026 · strength 1.16
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Masatoshi Murakami · 6 shared papers, 2020–2026 · strength 1.01
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Akihisa Ohno · 5 shared papers, 2022–2026 · strength 0.90
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Kohei Nakata · 3 shared papers, 2022–2024 · strength 0.44
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Paper Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer. DOI 10.1186/s12885-022-10207-0↗
- Paper Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic canc… DOI 10.1007/s12672-021-00462-1↗
- Yoshinao Oda · 2 shared papers, 2024–2026 · strength 0.41
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Takehiro Takaoka · 2 shared papers, 2023–2024 · strength 0.37
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable p… DOI 10.1111/ajco.13903↗
- Masafumi Nakamura · 2 shared papers, 2022 · strength 0.27
- Masafumi Nakamura · 1 shared paper, 2024 · strength 0.17
- Tsukasa Miyagahara · 1 shared paper, 2023 · strength 0.15
- Koki Oyama · 1 shared paper, 2022 · strength 0.14
- Kousei Ishigami · 1 shared paper, 2022 · strength 0.13
- Toshiya Abe · 1 shared paper, 2022 · strength 0.13
- Noboru Ideno · 1 shared paper, 2022 · strength 0.13
- Naoki Ikenaga · 1 shared paper, 2022 · strength 0.13
- Tomoharu Yoshizumi · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.